Arkansas recalls
3392 federal recalls on file affecting Arkansas - 317 Arkansas-specific plus 3075 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-01-28FDA-DeviceLeaseir TechnologiesClass IINationwideCheck your Leaseir MHR Xcell laser console label
The console label for affected devices is missing the "DANGER" symbol.
- 2026-01-28FDA-DeviceMerit MedicalClass IINationwideStop using Merit Medical angioplasty packs
Inflation device handle may detach from the syringe during procedure.
- 2026-01-28FDA-DeviceMerit MedicalClass IINationwideStop using Merit Medical Custom Procedure Kits
Inflation device handle may detach from the syringe during procedure.
- 2026-01-28FDA-DeviceMerit MedicalClass IINationwideStop using Merit Medical Custom Manifold Kit
Inflation device handle may detach from the syringe during procedure.
- 2026-01-28FDA-DeviceMerit MedicalClass IINationwideStop using Merit Medical inflation kits
Inflation device handle may detach from the syringe during procedure.
- 2026-01-28FDA-DeviceMerit MedicalClass IINationwideStop using Merit Medical vascular tray immediately
Inflation device handle may detach from the syringe during procedure.
- 2026-01-28FDA-DeviceMerit MedicalClass IINationwideStop using Merit Medical Allwell Inflation Device
Inflation device handle may detach from the syringe during procedure.
- 2026-01-28FDA-DeviceMerit MedicalClass IINationwideStop using recalled Merit Medical inflation device
Inflation device handle may detach from the syringe during procedure.
- 2026-01-28FDA-DeviceMazor RoboticsClass IINationwideCheck Mazor X robotic system software
Software errors that can result in incorrect surgical instrument positioning during spinal surgery.
- 2026-01-28FDA-DeviceBaxterClass IINationwideStop using recalled Baxter SIGMA Spectrum pump
Certain pumps have potentially been released from service with defective grease applied to the cam and motor gears. Due to its low viscosity, the defective grease may lead to the device having insufficient lubrication on the cam, which could lead to premature wear of the mechanism assembly, resulting in over-infusion or a free-flow situation.
- 2026-01-28FDA-DeviceICU MedicalClass IINationwideContact ICU Medical about Plum Solo IV Pump
Plum Solo and Duo Infusion pumps include a feature, that when selected, automatically flushes the downstream line after a piggyback therapy. The programmed flush volume is delivered from the primary line container at the piggyback therapy rate after the piggyback therapy is complete. In certain cases, as described below, the clinician may receive an Upper Hard Limit (UHL) or Lower Hard Limit (LHL) Violation message when programming a piggyback flush, which prevents the flush from being programmed.
- 2026-01-28FDA-DeviceICU MedicalClass IINationwideCheck ICU Medical Plum Duo IV Pump software
Plum Solo and Duo Infusion pumps include a feature, that when selected, automatically flushes the downstream line after a piggyback therapy. The programmed flush volume is delivered from the primary line container at the piggyback therapy rate after the piggyback therapy is complete. In certain cases, as described below, the clinician may receive an Upper Hard Limit (UHL) or Lower Hard Limit (LHL) Violation message when programming a piggyback flush, which prevents the flush from being programmed.
- 2026-01-28FDA-DeviceICU MedicalClass IINationwideCheck your ICU Medical Plum Duo pump software
Plum Solo and Duo Infusion pumps include a feature, that when selected, automatically flushes the downstream line after a piggyback therapy. The programmed flush volume is delivered from the primary line container at the piggyback therapy rate after the piggyback therapy is complete. In certain cases, as described below, the clinician may receive an Upper Hard Limit (UHL) or Lower Hard Limit (LHL) Violation message when programming a piggyback flush, which prevents the flush from being programmed.
- 2026-01-28FDA-DevicePhilipsClass IIContact Philips about your Azurion X-ray system
Philips has identified two (2) software issues affecting device systems that may result in loss of imaging (X-ray) functionality and/or loss of motorized movement, and/or incorrect image content and/or loss of data. Issue 1 - System remains in continuous restart mode after the start-up. Issue 2 - Longitudinal Position Error Applicable only to systems with Poly-G3 frontal stand.
- 2026-01-28FDA-DeviceGE HealthcareClass IINationwideCheck your GE Omni Legend PET scanner
There is a potential intermittent issue on certain Omni Legend systems that can result in a streaking artifact in the PET clinical scan images. This streaking artifact is most easily identified in transaxial slices on the acquisition console (both corrected and non-corrected for attenuation).
- 2026-01-28FDA-DeviceICU MedicalClass IINationwideStop using ICU Medical Tego Connectors
Needle free access device intended as accessory to vascular access used in hemodialysis or accessory to intravascular administration sets has a silicone seal which may bulge at the top, separate from the body, tear; may result in fluid leaks, occluded fluid flow, inability to inject/withdraw blood product, delayed/interrupted therapy, exposure to biological contaminants, air infused into the body
- 2026-01-28FDA-DeviceRaysearch LaboratoriesClass IINationwideUpdate RayStation treatment planning software
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
- 2026-01-28FDA-DeviceRaysearch LaboratoriesClass IINationwideUpdate RayStation 2024B software immediately
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
- 2026-01-28FDA-DeviceRaysearch LaboratoriesClass IINationwideCheck RayStation software versions 2024A SP1 and SP2
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
- 2026-01-28FDA-DeviceRaysearch LaboratoriesClass IINationwideUpdate RaySearch RayStation software immediately
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
- 2026-01-28FDA-DeviceRaysearch LaboratoriesClass IINationwideCheck RayStation software for dose calculation issues
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
- 2026-01-28FDA-DeviceRaysearch LaboratoriesClass IINationwideCheck RayStation software versions for dose calculation bug
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
- 2026-01-28FDA-DeviceRaysearch LaboratoriesClass IINationwideContact RaySearch about RayStation software update
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
- 2026-01-28FDA-DeviceRaysearch LaboratoriesClass IINationwideCheck RayStation versions 11.0.0–11.0.4 for dose issues
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
- 2026-01-28FDA-DeviceRaysearch LaboratoriesClass IINationwideCheck RayStation/RayPlan 10B for dose calculation issues
Potential for the invalidation for calculated radiation dose does not work as intended for certain Regions of Interest (ROIs). This issue occurs for some ROI(s) which have no contours and either have a material override defined, or are of type Bolus, Fixation, or Support. In these cases, adding geometry to the ROI, subsequently modifying geometry, or removing the material override does not invalidate dose as intended.
- 2026-01-28FDA-DrugZydusClass IINationwideStop using Zydus Icosapent Ethyl capsules
Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules
- 2026-01-28FDA-DrugSpecialty Process LabsClass IINationwideStop using Specialty Process Labs Thyroid USP
Subpotent Drug
- 2026-01-28FDA-DrugGraviti PharmaceuticalsClass IINationwideStop using Rising Pharmaceuticals Furosemide tablets
Presence of Foreign Substance
- 2026-01-28FDA-DrugCiplaClass IIINationwideStop using Cipla Diclofenac Sodium Topical Gel
Failed PH Specifications
- 2026-01-22CPSCResoulNationwideStop using Mikario Trading baby gyms immediately
The recalled baby gyms violate the mandatory safety standard for infant support cushions because the floor mats can obstruct an infant's breathing, posing a serious risk of injury or deadly suffocation hazard.
Get notified about new Arkansas recalls
Free weekly digest. Add Arkansas to your profile to filter alerts to your state.
Get the Sunday Brief